No Prescription |
 |
 | ||
|
Levoxyl |
|
| ||
No Prescription » Prescription Drugs 10 » Levoxyl ELTROXIN contains the active ingredient levothyroxine.ELTROXIN is used to treat hypothyroidism a disease in which the thyroid gland is underactive and does not produce enough thyroxine a hormone which is important for controlling your metabolism. Symptoms of hypothyroidism include tiredness muscle weakness cramps feeling the cold a slow heart rate dry and flaky skin hair loss a deep husky voice and weight gain.ELTROXIN is also used to treat children born with hypothyroidism (congenital) those who develop hypothyroidism in the first year of life (neonatal) and children who have hypothyroidism as part of juvenile myxoedema a condition in which the amount of thyroxine produced by the body is low.ELTROXIN belongs to a small group of medicines called thyroid hormones which work by replacing the body's low levels of thyroxine. Buy Levoxyl and other Prescription Drugs 10 products online at Medstore. Buy Online at Medstore - Click Here!
About Levoxyl: Product Type: Prescription Drugs 10 Levoxyl/Eltroxin ( Generic Levothyroxine ) Levoxyl/Eltroxin (Generic Levothyroxine) Generic Levothyroxine 100mcg Generic Levothyroxine Levoxyl/Eltroxin
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
